Clinical trial Recruiting at 1 site Interventional Ages 18 to 83

See if short-term supervised resistance training improves muscle health and function in frail older adults with type 2 diabetes

Official title: Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise

Run by Fundación para la Investigación del Hospital Clínico de Valencia · NCT07828847 · Data updated 2026-11-12

This study tests whether a brief, supervised resistance training program can improve skeletal muscle health and physical function in frail adults over 65 who have type 2 diabetes.

Quick facts

Study typeInterventional
Ages18 Years to 83 Years
SexAll
Enrollment120 (estimated)
SponsorFundación para la Investigación del Hospital Clínico de Valencia
Academic / other
Locations1 site (Valencia)
StatusRecruiting
StartedJanuary 29, 2022
Main results expectedJuly 31, 2028
Study endsJuly 31, 2028
Registry record updatedSeptember 18, 2026
Trial IDNCT07828847 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 65 with frailty and type 2 diabetes managed with metformin, not currently in a resistance training program.

Probably not a fit

Individuals without frailty, without type 2 diabetes, or those already engaging in resistance training may see limited or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial investigates the link between skeletal muscle mitochondrial dysfunction and frailty in older adults and whether a short, supervised resistance training intervention can improve muscle bioenergetics and physical performance. It includes older adults with frailty and type 2 diabetes, as well as control groups of healthy young and older adults. Participants will undergo a brief resistance training program and assessments of muscle function and metabolic biomarkers. The study aims to clarify cellular mechanisms related to frailty and the potential benefits of exercise for this population. Outcomes focus on feasibility, safety, and changes in muscle health and functional measures.

Why it matters

Potential benefit: If successful, the intervention could improve muscle strength, endurance, and overall function in frail older adults with type 2 diabetes.

How similar studies have gone: Prior research shows resistance training can improve muscle function in older adults, though the specific link to mitochondrial dysfunction in frailty with diabetes is an area of ongoing study.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inclusion criteria for young controls

  * Healthy young adults (18-35 years old)
  * Without any pathology or treatment
* Inclusion criteria for older controls

  * Healthy older adults (65 years or older)
  * Not currently enrolled in a resistance training program
* Inclusion criteria for cases

  * Age over 65 years
  * Diagnosis of frailty or robustness
  * Diagnosis of type 2 diabetes mellitus
  * Glycosylated hemoglobin (HbA1c) less than 9%
  * Treatment with metformin
  * Not currently enrolled in a resistance training program

Exclusion Criteria:

* Exclusion criteria for young controls

  * Pregnancy or suspected pregnancy
  * Body mass index greater than 35 kg/m2
  * Treatment within the last 30 days with oral corticosteroids
  * Edema or severe fluid regulation disorders that could alter bioimpedance results
  * Allergy to the local anesthetic mepivacaine
  * Prostheses, metal implants, or surgical staples lodinated or barium contrast for other imaging tests within the last 7 days
* Exclusion criteria for older controls

  * Decompensated and uncontrolled chronic diagnoses
  * Body mass index greater than 35 kg/m2
  * Treatment within the last 30 days with oral corticosteroids
  * Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease (COPD).
  * Severe edema or fluid regulation disorders that could alter bioimpedance results
  * Allergy to the local anesthetic mepivacaine
  * Prostheses, metal implants, or surgical staples Iodinated or barium contrast for other imaging tests in the last 7 days
* Exclusion criteria for cases

  * Diagnosis of pre-frailty
  * Age over 80 years
  * Body mass index greater than 35 kg/m2
  * Time since onset of diabetes mellitus type 2 less than 10 years
  * Treatment with insulin
  * Treatment with allopurinol
  * Treatment with anticoagulant or antiplatelet drugs
  * Treatment within the last 30 days with oral corticosteroids
  * Advanced chronic complications of diabetes mellitus type 2 :

Renal failure (clearance \<30 ml/min/m2) Macroalbuminuria greater than 200 mg/g Ischemic vascular diseases (acute myocardial infarction) Myocardial infarction, angina, stroke) Proliferative retinopathy or laser therapy Ulcerated diabetic foot or lower limb amputations, except for digital amputations

* Systemic diseases, active oncological disease, liver cirrhosis, untreated hypothyroidism, or severe chronic obstructive pulmonary disease
* Physical limitations in the lower limbs (acute or acute-on-chronic inflammatory processes, limited joint range of motion, chronic pain (visual analogue scale for pain \> or = 4, etc.)
* Senile dementia
* Edema or severe fluid regulation disorders that may alter bioimpedance results
* Allergy to the local anesthetic mepivacaine
* Pacemaker, metallic prostheses or implants, surgical staples, and radiopaque tubes or catheters Iodinated or barium contrast for other imaging tests within the last 7 days

Where it's running

  • University of Valencia/Hospital Clínico Universitario de València,
    Valencia, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.